Andrew Saik

Andrew Saik is a declared insider at 3 companies (finance chief); the most frequent names are Intercept Pharmaceuticals, Inc., Arvinas, Inc. and Yarrow Bioscience, Inc. In total, 19 filings cover trades dated from 28 May 2021 to 24 June 2026.

Sales make up the whole of the open-market record (3 sales, €89k). The totals exclude 1 filing filed without an amount. Outside the open market, there are 15 share grants. In 2026 alone, the filings show no purchases and 2 sales.

The latest filing, published on 24 June 2026, reports an open-market sale in Arvinas, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.